Trials / Completed
CompletedNCT00000450
Naltrexone Maintenance Treatment of Alcoholism
Nalmefene Maintenance Treatment of Alcoholism
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 159 (actual)
- Sponsor
- The Scripps Research Institute · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the long-term effectiveness of naltrexone treatment in alcohol-dependent patients who respond to short-term treatment. Those who respond to short-term treatment will be randomized to a 1-year, double-blind, placebo-controlled maintenance phase with a 6-month posttreatment followup.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Naltrexone Tablet | |
| DRUG | Matched Placebo Tablet |
Timeline
- Start date
- 1997-04-10
- Primary completion
- 2002-02-13
- Completion
- 2002-02-13
- First posted
- 1999-11-03
- Last updated
- 2017-04-20
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT00000450. Inclusion in this directory is not an endorsement.